{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:00:49Z","timestamp":1784257249440,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":3160,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1093\/annonc\/mdq449","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T21:12:29Z","timestamp":1287436349000},"page":"924-930","source":"Crossref","is-referenced-by-count":77,"title":["First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study"],"prefix":"10.1016","volume":"22","author":[{"given":"M.L.","family":"Garc\u00eda de Paredes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"del Moral Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez del Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Mart\u00ed Ciriqui\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Enrech Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cobo Dols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Esteban Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Ortega Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Majem Tarruella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Cumplido Bur\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gasc\u00f3 Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"L\u00f3pez Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Ciria Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"de Castro Carpe\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq449_bb0010","first-page":"553","article-title":"[Management of cancer pain.]","volume":"24","author":"Khosravi Shahi","year":"2007","journal-title":"An Med Interna"},{"key":"10.1093\/annonc\/mdq449_bb0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/1097-0142(19920915)70:6<1616::AID-CNCR2820700630>3.0.CO;2-7","article-title":"Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect","volume":"70","author":"Portenoy","year":"1992","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq449_bb0020","series-title":"Classification of Chronic Pain","first-page":"209","article-title":"Part III: pain terms, a current list with definitions and notes on usage","author":"Merskey","year":"1994"},{"key":"10.1093\/annonc\/mdq449_bb0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jpainsymman.2003.04.002","article-title":"Analysis and treatment of different types of neuropathic cancer pain","volume":"26","author":"Stute","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdq449_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician","volume":"175","author":"Gilron","year":"2006","journal-title":"CMAJ"},{"key":"10.1093\/annonc\/mdq449_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1533-2500.2006.00054.x","article-title":"Epidemiology of refractory neuropathic pain","volume":"6","author":"Taylor","year":"2006","journal-title":"Pain Pract"},{"key":"10.1093\/annonc\/mdq449_bb0040","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.PHM.0000154905.18445.0F","article-title":"Management of peripheral neuropathic pain","volume":"84","author":"Stacey","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdq449_bb0045","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1526-4637.2004.04020.x","article-title":"Pharmacologic management part 1: better-studied neuropathic pain diseases","volume":"5","author":"Backonja","year":"2004","journal-title":"Pain Med"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdq449_bb0050","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1111\/j.1526-4637.2004.04021.x","article-title":"Pharmacologic management part 2: lesser-studied neuropathic pain diseases","volume":"5","author":"Backonja","year":"2004","journal-title":"Pain Med"},{"key":"10.1093\/annonc\/mdq449_bb0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jpain.2008.12.002","article-title":"Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients","volume":"10","author":"Mercadante","year":"2009","journal-title":"J Pain"},{"key":"10.1093\/annonc\/mdq449_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer pain and analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/annonc\/mdq449_bb0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0885-3924(01)00420-1","article-title":"Problems recruiting cancer patients to a comparative clinical trial of drug treatments for neuropathic pain in palliative care","volume":"23","author":"Sinnott","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdq449_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7525-5-66","article-title":"Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component","volume":"5","author":"Perez","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"10.1093\/annonc\/mdq449_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"10.1093\/annonc\/mdq449_bb0080","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.64.12_suppl_3.S21","article-title":"Contemporary assessment and management of neuropathic pain","volume":"64","author":"Irving","year":"2005","journal-title":"Neurology"},{"key":"10.1093\/annonc\/mdq449_bb0085","first-page":"385","article-title":"[Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. PREVADOL study]","volume":"20","author":"Montero Homs","year":"2005","journal-title":"Neurologia"},{"key":"10.1093\/annonc\/mdq449_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-3959(99)00073-1","article-title":"An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain","volume":"82","author":"Caraceni","year":"1999","journal-title":"Pain"},{"key":"10.1093\/annonc\/mdq449_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(98)00138-9","article-title":"Assessment and treatment of neuropathic cancer pain following WHO guidelines","volume":"79","author":"Grond","year":"1999","journal-title":"Pain"},{"key":"10.1093\/annonc\/mdq449_bb0100","doi-asserted-by":"crossref","first-page":"110S","DOI":"10.1002\/j.1875-9114.1997.tb03813.x","article-title":"Clinical overview of the taxanes","volume":"17","author":"Goldspiel","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1093\/annonc\/mdq449_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1634\/theoncologist.6-1-56","article-title":"The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer","volume":"6","author":"Blum","year":"2001","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq449_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00686839","article-title":"Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer","volume":"35","author":"Adenis","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdq449_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/theoncologist.9-suppl_2-16","article-title":"Taxane-platinum combinations in advanced non-small cell lung cancer: a review","volume":"9","author":"Rigas","year":"2004","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq449_bb0120","first-page":"4807","article-title":"Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer","volume":"115","author":"Nurgalieva","year":"2009","journal-title":"Am J Ther"},{"key":"10.1093\/annonc\/mdq449_bb0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrclinonc.2009.43","article-title":"Medical Oncology: IROX as second-line therapy for metastatic colorectal cancer","volume":"6","author":"Sobrero","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdq449_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bja\/aen100","article-title":"Translational medicine: cancer pain mechanisms and management","volume":"101","author":"Delaney","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1093\/annonc\/mdq449_bb0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1871520610909030326","article-title":"The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: from theory to clinical practice","volume":"9","author":"Vassiliou","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1093\/annonc\/mdq449_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3959(94)90058-2","article-title":"Pain characteristics of advanced lung cancer patients referred to a palliative care service","volume":"59","author":"Mercadante","year":"1994","journal-title":"Pain"},{"key":"10.1093\/annonc\/mdq449_bb0145","author":"C\u00eda","year":"2006","journal-title":"Tolerance and effectiveness of oxycodone in patients with mixed lumbar pathology presenting intolerance to other opiates"},{"key":"10.1093\/annonc\/mdq449_bb0150","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1093\/annonc\/mdq449_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419385576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419385576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/4\/924\/569530\/mdq449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T13:42:02Z","timestamp":1711892522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419385576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0923753419385576"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq449","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}